STOCKHOLDERS’ DEFICIT |
3 Months Ended | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2026 | ||||||||||||||||||||||
| Equity [Abstract] | ||||||||||||||||||||||
| STOCKHOLDERS’ DEFICIT | 7. STOCKHOLDERS’ DEFICIT
Series B Preferred Stock
Effective March 2021, pursuant to authority of its Board of Directors, the Company filed a Certificate of Determination for its Series B Preferred Stock. The Series B Preferred Stock has a par value of $ per shares and consists of shares.
Terms of the Series B Preferred include the following:
Common Stock Issued for Services
On May 1, 2025, the Company entered into a consulting agreement for services. Pursuant to the agreement, the Company agreed to issue up to shares of restricted common stock as compensation over an initial 12-month service period, including an initial issuance of shares upon execution and monthly issuances of shares beginning July 1, 2025. The initial shares were issued in May 2025 and were valued at $10,000. During the third and fourth quarter of 2025, the Company issued an additional shares under this arrangement, with an aggregate fair value of $20,000. During the first quarter of 2026, the Company issued an additional shares under this arrangement, with an aggregate fair value of $8,000. For the three months ended March 31, 2026, the Company recognized stock-based compensation expense of $ related to this agreement. The remaining unrecognized compensation cost of $ is expected to be recognized over the remaining service period (See Note 9).
On January 1, 2026, the Company entered into a consulting agreement for services. Pursuant to the agreement, the Company issued shares of restricted common stock as compensation for a 12-month service period. The shares were valued at $3,000. For the three months ended March 31, 2026, the Company recognized stock-based compensation expense of $ related to this agreement. The remaining unrecognized compensation cost of $ is expected to be recognized over the remaining service period (See Note 9).
As of the date of this report, the above mentioned shares have not been issued by the transfer agent; however, the Company has recorded the shares as common stock to be issued and recognized the related stock based compensation expense.
Debt Settlement and Stock Issuance
In January 2026, the Company entered into a settlement agreement with the holder of certain promissory notes originally issued in 2021 and 2022. As of the settlement date, the aggregate carrying value of the outstanding debt was approximately $172,500 (see Note 6). Pursuant to the settlement, all outstanding notes were cancelled and extinguished. In exchange, the Company agreed to (i) pay $20,000 in cash, payable in four monthly installments of $5,000, and (ii) issue shares of the Company’s common stock. In connection with the settlement agreement, the $20,000 cash payment obligation was reclassified to settlement payable and included in accrued expenses. The Company made the first three installment payments totaling $15,000 in the first quarter of 2026, and the final $5,000 was paid in April 2026 (see Note 8). The common shares issued in connection with the settlement were valued based on the Company’s trading price of $0.0002 per share, resulting in a fair value of $12,000. We recognized a gain on debt settlement of $140,500 during the first quarter of 2026, representing the excess of the carrying amount of the debt over the fair value of the consideration transferred. The gain on settlement is included in the accompanying condensed consolidated statements of operations.
|